sirna targeting bi 1 (Santa Cruz Biotechnology)
Structured Review

Sirna Targeting Bi 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bi+1+sirna/BI-1+siRNA/pmc06898997-329-7-11
Average 92 stars, based on 1 article reviews
Images
1) Product Images from "Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model"
Article Title: Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model
Journal: Disease Models & Mechanisms
doi: 10.1242/dmm.040352
Figure Legend Snippet: Expression levels of endogenous BI-1, IRE1α, XBP1 and CHOP post-HI. (A) Representative immunoblots showing protein expression levels in ipsilateral hemispheric tissue from 10-day-old neonatal rats. (B–E) Quantitative analysis of BI-1 (B), IRE1α (C), XBP1 (D) and CHOP (E) time-dependent expression after HI (band density relative to actin). Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus 6 h, @ P <0.05 versus 24 h; n =4. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis.
Techniques Used: Expressing, Western Blot
Figure Legend Snippet: Ad-TMBIM6 administered at 48 h pre-HI reduced percentage infarcted area and showed localization to neurons and microglia at 72 h post-HI. (A) Representative images of TTC-stained sections and quantification of percentage infarcted area at 72 h post-HI in brain tissue from neonatal rats expressing BI-1 through adenoviral transduction with Ad-TMBIM6. Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus vehicle, n =6. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis. (B–E) Representative microphotographs of double immunofluorescence staining of BI-1 (red) with neurons (NeuN, green) (B), IRE1α (red) with neurons (NeuN, green) (C), BI-1 (red) with astrocytes (GFAP, green) (D) and BI-1 (red) with microglia (Iba-1, green) (E) in the peri-infarcted area at 72 h post-HI. Blue, DAPI. n =1/group. Merged images show localization of BI-1 or IRE1α to neurons, astrocytes or microglia. There was minimal localization of BI-1 to astrocytes. Scale bars: 50 μm.
Techniques Used: Staining, Expressing, Transduction, Double Immunofluorescence Staining
Figure Legend Snippet: Expression of BI-1 improved long-term neurological deficits at 4 weeks post-HI. (A,B) In rat pups expressing BI-1 through treatment with Ad-TMBIM6 , long-term motor, learning and memory were assessed via foot fault test (A) and water maze test (B) at 4 weeks post-HI. (C,D) Quantitative analysis of percentage of weight of ipsilateral and contralateral regions out of total brain weights (C) and percentage of tissue loss (D) at 4 weeks post-HI. Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus vehicle; n =6–9. One-way ANOVA followed by Tukey multiple-comparison or Holm–Sidak post hoc analysis.
Techniques Used: Expressing, Hi-C
Figure Legend Snippet: Effects of BI-1 siRNA and IRE1α CRISPR activation plasmid on infarct area at 72 h post-HI. (A,B) Representative images of infarcted tissue (A) and quantification of percentage infarcted area (out of total brain area) (B) at 72 h post-HI. Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus vehicle; @ P <0.05 versus Ad-TMBIM6; $ P <0.05 versus BI-1 siRNA; + P <0.05 versus Ad-TMBIM6+scramble siRNA; & P <0.05 versus IRE1α CRISPR AP; % P <0.05 versus control CRISPR. n =6/group. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis. (C) Representative schematic of BI-1/IRE1α/XBP1/CHOP signaling pathway using the intervention groups (BI-1 siRNA and IRE1α CRISPR activation plasmid) to study the mechanism. (D) Representative immunofluorescence staining of BI-1 (red) with neurons (NeuN, green), astrocytes (GFAP, green) and microglia (Iba-1, green) after siRNA administration. Representative picture demonstrating brain region from where immunofluorescence pictures were obtained is shown upper right. n =1/group. Scale bars: 50 μm.
Techniques Used: CRISPR, Activation Assay, Plasmid Preparation, Immunofluorescence, Staining
Figure Legend Snippet: BI-1 exerted its protective effects via the IRE1α–XBP1–CHOP pathway at 72 h post-HI. (A) Representative immunoblots of protein expression levels in ipsilateral hemispheric tissue from 10-day-old rats at 72 h post-HI. (B–F) Quantitative analysis of BI-1 (B), pIRE1α (C), XBP1 (D), CHOP (E) and ROMO1 (F) expression levels (band density relative to actin). Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus vehicle; @ P <0.05 versus Ad-TMBIM6; $ P <0.05 versus BI-1 siRNA; + P <0.05 versus Ad-TMBIM6+scramble siRNA; & P <0.05 versus IRE1α CRISPR AP; % P <0.05 versus control CRISPR; ^ P <0.05 versus Ad-TMBIM6+BI-1 siRNA; ε P <0.05 versus BI-1 siRNA-only group. n =6/group. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis.
Techniques Used: Western Blot, Expressing, CRISPR
Figure Legend Snippet: Overexpression of BI-1 attenuated apoptosis at 72 h post-HI. (A) Representative immunoblots of protein expression levels in ipsilateral hemispheric tissue from 10-day-old rats at 72 h post-HI. (B–D) Quantification of Bcl-2 (B), BAX (C) and CC3 (D) expression level data (band density relative to actin). Data presented as mean±s.d.; * P <0.05 versus sham; # P <0.05 versus vehicle; @ P <0.05 versus Ad-TMBIM6; $ P <0.05 versus BI-1 siRNA; + P <0.05 versus Ad-TMBIM6+scramble siRNA; & P <0.05 versus IRE1α CRISPR AP; % P <0.05 versus control CRISPR. n =6/group. One-way ANOVA followed by Tukey multiple-comparison, Holm–Sidak or Dunnett's post hoc analysis. (E) Representative microphotographs of positively CC3-stained (red) neurons (NeuN, green) from 10-day-old rats at 72 h post-HI. (F) Representative microphotographs of Fluoro-Jade C (FJC)-positive degenerating neurons in the peri-infarcted area. n =1/group. Scale bars: 100 µm.
Techniques Used: Over Expression, Western Blot, Expressing, CRISPR, Staining
Figure Legend Snippet: Percentage cell viability significantly improved after transfection of PC-12 cells with Ad-TMBIM6 at MOI=100 in an in vitro OGD model. (A) Quantification of data shows time-dependent decrease in percentage cell viability for cultured PC12 cells when exposed to 1 h, 1.5, 3 h, 5 h and 6 h in OGD. (B) Quantification analysis of percentage cell viability of PC12 cells when exposed to varying concentrations (MOI) of viral vector. (C) Representative images of cell morphology and density of cells after OGD in all groups. Scale bar: 100 µm. (D) Quantification analysis of percentage cell viability with pathway interventions. Data presented as mean± s.d.; * P <0.05 versus control; # P <0.05 versus vehicle; @ P <0.05 versus Ad-TMBIM6+scramble siRNA (D) or versus MOI=100 (B); ε P <0.05 versus Ad-TMBIM6 only; $ P <0.05 versus BI-1 siRNA; & P <0.05 versus APY-29; + P <0.05 versus DMSO; % P <0.05 versus CCT020312; ^ P <0.05 versus STF-083010 and control CRISPR. n =5–6/group. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis.
Techniques Used: Transfection, In Vitro, Cell Culture, Plasmid Preparation, CRISPR
Figure Legend Snippet: BI-1 exerted its anti-apoptotic effects via inhibition of IRE1α in an in vitro OGD model. (A) Representative immunoblots of protein expression levels in PC12 cultured cells. Quantification of BI-1 (B), pIRE1α (C), pPERK (D) and CC3 (E) expression levels (band density relative to actin). Data presented as mean±s.d.; * P <0.05 versus control; # P <0.05 versus vehicle; @ P <0.05 versus Ad-TMBIM6 and Ad-TMBIM6+scramble siRNA; $ P <0.05 versus BI-1 siRNA; & P <0.05 versus APY-29; + P <0.05 DMSO; % P <0.05 versus CCT020312; ^ P <0.05 versus STF-083010 and control CRISPR. n =5–6/group. One-way ANOVA followed by Tukey multiple-comparison post hoc analysis.
Techniques Used: Inhibition, In Vitro, Western Blot, Expressing, Cell Culture, CRISPR
Related Articles
CRISPR:Article Title: Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model Article Snippet: Human adenoviral TMBIM6 vector (Ad-TMBIM6) (ADV-225645, Vector Biolabs) was injected intracerebroventricularly (icv) at 2 μl containing 1.6×10 11 PFU/ml per injection ( ) at 72 h, 48 h and 24 h pre-HI and 1 h post-HI. .. Activation Assay:Article Title: Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model Article Snippet: Human adenoviral TMBIM6 vector (Ad-TMBIM6) (ADV-225645, Vector Biolabs) was injected intracerebroventricularly (icv) at 2 μl containing 1.6×10 11 PFU/ml per injection ( ) at 72 h, 48 h and 24 h pre-HI and 1 h post-HI. .. Plasmid Preparation:Article Title: Adenoviral TMBIM6 vector attenuates ER-stress-induced apoptosis in a neonatal hypoxic-ischemic rat model Article Snippet: Human adenoviral TMBIM6 vector (Ad-TMBIM6) (ADV-225645, Vector Biolabs) was injected intracerebroventricularly (icv) at 2 μl containing 1.6×10 11 PFU/ml per injection ( ) at 72 h, 48 h and 24 h pre-HI and 1 h post-HI. .. |
